Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.

Takahashi Y, Hasegawa H, Hara Y, Ato M, Ninomiya A, Takagi H, Odagiri T, Sata T, Tashiro M, Kobayashi K.

J Infect Dis. 2009 Jun 1;199(11):1629-37. doi: 10.1086/598954.

2.

Seasonal inactivated influenza virus vaccines.

Couch RB.

Vaccine. 2008 Sep 12;26 Suppl 4:D5-9. doi: 10.1016/j.vaccine.2008.05.076. Review.

3.

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, Sigurdardottir B, Hoeper A, Graham IL, Edelman R, He F, Nino D, Capellan J, Ruben FL.

Vaccine. 2007 Nov 1;25(44):7656-63. Epub 2007 Sep 14.

4.
5.

Neuraminidase inhibitors for influenza.

Moscona A.

N Engl J Med. 2005 Sep 29;353(13):1363-73. Review. No abstract available.

6.

An overview of serum antibody responses to influenza virus antigens.

Couch RB.

Dev Biol (Basel). 2003;115:25-30. Review.

PMID:
15088772
8.

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Powers DC, Kilbourne ED, Johansson BE.

Clin Diagn Lab Immunol. 1996 Sep;3(5):511-6.

9.

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.

Kilbourne ED, Couch RB, Kasel JA, Keitel WA, Cate TR, Quarles JH, Grajower B, Pokorny BA, Johansson BE.

Vaccine. 1995 Dec;13(18):1799-803.

PMID:
8701596
10.
11.

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

Murphy BR, Kasel JA, Chanock RM.

N Engl J Med. 1972 Jun 22;286(25):1329-32. No abstract available.

PMID:
5027388
12.

Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Kilbourne ED, Laver WG, Schulman JL, Webster RG.

J Virol. 1968 Apr;2(4):281-8.

13.

Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

Couch RB, Kasel JA, Gerin JL, Schulman JL, Kilbourne ED.

J Infect Dis. 1974 Apr;129(4):411-20. No abstract available.

PMID:
4593871
14.

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Palese P, Tobita K, Ueda M, Compans RW.

Virology. 1974 Oct;61(2):397-410. No abstract available.

PMID:
4472498
16.

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.

Kilbourne ED, Johansson BE, Grajower B.

Proc Natl Acad Sci U S A. 1990 Jan;87(2):786-90.

17.

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates.

Lambré CR, Terzidis H, Greffard A, Webster RG.

J Immunol Methods. 1990 Dec 31;135(1-2):49-57.

PMID:
1703190
18.

Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.

Ogra PL, Chow T, Beutner KR, Rubi E, Strussenberg J, DeMello S, Rizzone C.

J Infect Dis. 1977 Apr;135(4):499-506.

PMID:
856917
Items per page

Supplemental Content

Write to the Help Desk